The SCCS has published a preliminary opinion open to comment on Silver Zinc Zeolite. This opinion is issued based on the request for an opinion to the SCCS by the Commission on Silver Zinc Zeolite taking into account the classification as Toxic for reproduction Cat....
Legal Cosmetic Area
Hydroxyapatite (nano) – Final Opinion
The SCCS has published the final opinion on Hydroxyapatite (nano). On January 11, 2023, a preliminary Opinion was issued on this ingredient, which concluded aspects of the safety of Hydroxyapatite at certain concentrations. In the final opinion on the evaluation of...
Sodium Bromothymol Blue – Final Opinion
The SCCS has published the final opinion on Sodium Bromothymol Blue. On October 28, 2022, a Preliminary Opinion was issued on this ingredient where it was concluded that its safety could not be assessed based on the data provided. In the current opinion on the...
Aluminium – Final opinion
The SCSS has published its final opinion on the safety of using Aluminium in cosmetic products. After the issuance of the preliminary opinion of the SCCS on this ingredient on May 30, 2022, the final opinion has been published. In this opinion (SCCS/1644/22) the SCCS...
Alpha y beta arbutin- Final opinion
The SCCS has published the final opinion on the safety of alpha-arbutin and beta-arbutin, used in cosmetic products. A preliminary opinion on alpha and beta-arbutin had been issued on March 25, 2022. Alpha-arbutin and beta-arbutin are used in the formulation of face...
Hydroxyapatite (nano) – Preliminary opinion
The SCCS has published a preliminary opinion open to comment on Hydroxyapatite (nano). This opinion is issued based on the request for an opinion to the SCCS by the Commission on Hydroxyapatite (nano). In the aforementioned mandate, an opinion is requested regarding...
Salicylic Acid – Preliminary opinion
The SCCS has published its preliminary opinion, open for comment, on the cosmetic ingredient Salicylic Acid. Previously, the Commission made a request for an opinion to the SCCS on Salicylic Acid as a possible endocrine disruptor. Salicylic acid (CAS No 69-72-7, EC No...
Triclocarban and Triclosan – Final Scientific Advice
The SCCS has published the final conclusions of the scientific advice on the safety of Triclocarban and Triclosan. The purpose of the Commission's request for this advice was to identify and substantiate specific concerns regarding the safe use of Triclocarban and...
Vitamin A – Final opinion
The SCCS has published its final opinion on the cosmetic ingredient Vitamin A. Previously, the Commission made a request for the review of opinion SCCS/1576/16 on vitamin A as a cosmetic ingredient. The opinion revision is requested in light of new information on the...
Sodium bromothymol blue (C186) – Preliminary opinion
The SCCS has published its preliminary opinion on the cosmetic ingredient Sodium bromothymol blue (C186). On March 17, 2022, an opinion request was made to the SCCS on Sodium bromothymol blue (C186). Sodium bromothymol blue (C186) is intended for use as a hair dye in...
Meeting of the Working Group on Cosmetic Ingredients
On October 3 and 4, the meeting of the SCCS cosmetic ingredients working group took place. During the meeting various points related to new mandates and opinions were discussed. First, the mandate of A165 Submission II, Hydroxypropyl p-phenylenediamine and its...
Genistein y Daidzein – Final Opinion
The SCCS has published its final opinion on the cosmetic ingredients Genistein and Daidzein. Genistein and Daidzein are isoflavones, with the cosmetic functionalities of skin conditioning, antioxidant, and skin protectant. Currently, they are not regulated by the...

